BCL2 and ovarian carcinoma: In this work, we first selected cisplatin-sensitive (A2780s, IGROV1 and OAW42) and -resistant (A2780cp, OVCAR-3 and SKOV3) human ovarian cancer cell lines to test the expression variations of prosurvival and proapoptotic Bcl-2 family proteins.